New York State Common Retirement Fund’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-89,500
| Closed | -$304K | – | 3233 |
|
|
2018
Q3 | $304K | Hold |
89,500
| – | – | ﹤0.01% | 2649 |
|
|
2018
Q2 | $337K | Hold |
89,500
| – | – | ﹤0.01% | 2631 |
|
|
2018
Q1 | $366K | Hold |
89,500
| – | – | ﹤0.01% | 2488 |
|
|
2017
Q4 | $416K | Buy |
89,500
+7,600
| +9% | +$35.3K | ﹤0.01% | 2442 |
|
|
2017
Q3 | $581K | Sell |
81,900
-87,079
| -52% | -$618K | ﹤0.01% | 2286 |
|
|
2017
Q2 | $1.22M | Buy |
168,979
+28,401
| +20% | +$205K | ﹤0.01% | 1936 |
|
|
2017
Q1 | $866K | Buy |
140,578
+1
| +0% | +$6 | ﹤0.01% | 2107 |
|
|
2016
Q4 | $824K | Hold |
140,577
| – | – | ﹤0.01% | 2134 |
|
|
2016
Q3 | $746K | Buy |
140,577
+26,695
| +23% | +$142K | ﹤0.01% | 2134 |
|
|
2016
Q2 | $754K | Sell |
113,882
-27,100
| -19% | -$179K | ﹤0.01% | 2108 |
|
|
2016
Q1 | $658K | Sell |
140,982
-31,664
| -18% | -$148K | ﹤0.01% | 2143 |
|
|
2015
Q4 | $872K | Sell |
172,646
-172,157
| -50% | -$870K | ﹤0.01% | 2062 |
|
|
2015
Q3 | $1.21M | Sell |
344,803
-12,321
| -3% | -$43.4K | ﹤0.01% | 1838 |
|
|
2015
Q2 | $3.56M | Buy |
357,124
+138,585
| +63% | +$1.38M | 0.01% | 1537 |
|
|
2015
Q1 | $2.78M | Buy |
218,539
+46,382
| +27% | +$590K | ﹤0.01% | 1515 |
|
|
2014
Q4 | $2.44M | Hold |
172,157
| – | – | ﹤0.01% | 1538 |
|
|
2014
Q3 | $2.37M | Buy |
172,157
+63,638
| +59% | +$875K | ﹤0.01% | 1542 |
|
|
2014
Q2 | $1.67M | Buy |
108,519
+77,872
| +254% | +$1.2M | ﹤0.01% | 1725 |
|
|
2014
Q1 | $522K | Hold |
30,647
| – | – | ﹤0.01% | 1919 |
|
|
2013
Q4 | $397K | Buy |
+30,647
| New | +$397K | ﹤0.01% | 1925 |
|